Evidence map›Paper›PMID 41362515›Full record

ArticleCureus2025

Refractory Lupus Nephritis in a Woman With Systemic Lupus Erythematosus on Immunosuppressive Therapy: A Case Report.

Christopher H Goss, Ahmad Al Tumizi, Atul Singh

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Christopher H GossInternal Medicine, Charleston Area Medical Center, Charleston, USA.
Ahmad Al TumiziInternal Medicine, Charleston Area Medical Center, Charleston, USA.
Atul SinghInternal Medicine, Charleston Area Medical Center, Charleston, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Systemic lupus erythematosus (SLE) is a multisystem rheumatologic condition that can affect nearly every organ. Recognition of lupus nephritis, a subset of SLE, is critical to preserve organ function. In this case report, we highlight a case of combined class III and V lupus nephritis in a young woman with SLE who subsequently progressed to chronic kidney disease (CKD) stage IIIb while on treatment with immunosuppressants, despite adequate medication compliance. A 24-year-old African American woman with a history of SLE presented to our hospital with severe nephrotic-range proteinuria and new-onset lower extremity edema. She had refractory lupus, as evidenced by persistent proteinuria despite six months of immunosuppressive therapy. She was treated initially with steroids and azathioprine; however, over time her lupus flared and her kidney function worsened despite treatment with mycophenolate, steroids, and eventually voclosporin. To date, she has had several lupus flares while on treatment and appears to have progressed toward CKD stage IIIb.

Indexed as

chronic kidney disease (ckd)general internal medicinegeneral nephrologylupus nephritissystematic lupus erythematosus

Identifiers

PMID41362515
PMCPMC12682307

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.